bile
salt
kinetics
cystic
fibrosis
influence
pancreatic
enzyme
replacement
bile
acid
kinetics
investigated
stable
isotope
dilution
technique
child
age
month
year
previously
untreated
cystic
fibrosis
patient
clinical
laboratory
evidence
malabsorption
normal
intestinal
mucosal
function
judged
glucose
absorption
intestinal
histology
disaccharidase
level
normally
functioning
gallbladder
child
maintained
constant
diet
throughout
study
period
fat
intake
averaged
g
per
kg
per
day
administration
pancreatic
enzyme
replacement
fat
excretion
equalled
plus
minus
mean
plus
minus
se
intake
reduced
plus
minus
intake
therapy
total
bile
acid
pool
size
nearly
doubled
enzyme
replacement
plus
minus
micromoles
per
kg
plus
minus
micromoles
per
kg
secondary
bile
acid
comprising
total
pool
therapy
therapy
total
bile
acid
synthesis
changed
little
therapy
equalling
plus
minus
micromoles
per
kg
per
day
total
plus
minus
mg
per
day
without
enzyme
replacement
plus
minus
micromoles
per
kg
per
day
total
plus
minus
milligram
per
day
enzyme
replacement
confirmed
fecal
excretion
bile
acid
plus
minus
milligram
bile
acid
per
day
excreted
without
enzyme
compared
plus
minus
milligram
per
day
enzyme
therapy
fractional
turnover
rate
bile
acid
pool
reduced
plus
minus
per
day
plus
minus
per
day
cholic
acidand
plus
minus
per
day
plus
minus
per
day
chenodeoxycholic
acid
data
indicate
primary
secondary
bile
acid
conserved
within
enterohepatic
circulation
enzyme
therapy
mechanism
regulation
hepatic
bile
acid
synthesis
intact
cystic
fibrosis
however
demonstration
large
amount
bile
acid
continue
excreted
therapy
suggests
interruption
enterohepatic
circulation
continues
deficiency
intraluminal
phase
may
persist
enzyme
therapy
disease
